Free Trial

ReWalk Robotics Q4 2022 Earnings Report

ReWalk Robotics logo
$1.50 +0.01 (+0.67%)
(As of 12/20/2024 05:16 PM ET)

ReWalk Robotics EPS Results

Actual EPS
-$0.63
Consensus EPS
-$0.49
Beat/Miss
Missed by -$0.14
One Year Ago EPS
N/A

ReWalk Robotics Revenue Results

Actual Revenue
$2.18 million
Expected Revenue
$2.10 million
Beat/Miss
Beat by +$80.00 thousand
YoY Revenue Growth
N/A

ReWalk Robotics Announcement Details

Quarter
Q4 2022
Time
N/A

Conference Call Resources

This is the worst sign for the U.S. stock market in 50 years (Ad)

The Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts now says this is just the beginning of a new crisis that could be worse than the COVID crash, the dot-com crash, and even the Great Depression. Introducing "The Dead Zone"

Click here to see Dan's new, urgent warning about the U.S. market for 2025.

ReWalk Robotics Earnings Headlines

Wall Street Icon: “You must get on the right side of this thing”
I created one of the first quantitative analysis-based stock picking systems long before "quants" became a thing on Wall Street… leading Forbes to call me "King of the Quants." I'm writing to you today because my system has recently uncovered a market phenomenon I haven't seen in 30 years.
Lifeward reports Q3 adjusted EPS (45c) vs. (52c) last year
See More ReWalk Robotics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ReWalk Robotics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ReWalk Robotics and other key companies, straight to your email.

About ReWalk Robotics

ReWalk Robotics (NASDAQ:LFWD), a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.

View ReWalk Robotics Profile

More Earnings Resources from MarketBeat

Upcoming Earnings